Literature DB >> 16772891

The Charles F. Prentice Award Lecture 2005: optics of the human eye: progress and problems.

W Neil Charman1.   

Abstract

The history of measurements of ocular aberration is briefly reviewed and recent work using much-improved aberrometers and large samples of eyes is summarized. When on-axis, higher-order, monochromatic aberrations are averaged, undercorrected, positive, fourth-order spherical aberration dominates; other Zernike wavefront aberration coefficients have average values near zero. Individually, however, many eyes show substantial amounts of third-order and other fourth-order aberrations; the value of these varies idiosyncratically about zero. Most normal eyes show only small amounts of axial monochromatic aberration for photopic pupils up to around 3 mm; the limits to retinal image quality are then usually set by diffraction, uncorrected or imperfectly corrected spherocylindrical refractive error, accommodation error, and chromatic aberration. Longitudinal chromatic aberration varies very little across the population. With larger mesopic and scotopic pupils, monochromatic aberration plays a more important optical role, but overall visual performance is increasingly dominated by neural factors. Some remaining problems in measuring and modeling the eye's optical performance are discussed.

Entities:  

Mesh:

Year:  2006        PMID: 16772891     DOI: 10.1097/01.opx.0000221389.36278.d0

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  2 in total

1.  Photographic Depiction of the Field of View with Spectacles-mounted Low Vision Aids.

Authors:  Jae-Hyun Jung; Nish Mohith Kurukuti; Eli Peli
Journal:  Optom Vis Sci       Date:  2021-10-01       Impact factor: 1.973

2.  Comparison of Subjective Refraction under Binocular and Monocular Conditions in Myopic Subjects.

Authors:  Hidenaga Kobashi; Kazutaka Kamiya; Tomoya Handa; Wakako Ando; Takushi Kawamorita; Akihito Igarashi; Kimiya Shimizu
Journal:  Sci Rep       Date:  2015-07-28       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.